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Purpose: To investigate the association between visual changes and retinal vessel attenuation 
in patients with retinitis pigmentosa (RP).
Design: A retrospective, longitudinal, observational cohort study.
Methods: We analyzed 45 eyes from 45 subjects who were followed-up for 3 years at our 
clinic. Using the computer-based Interactive Vessel Analysis program, central retinal artery 
equivalent (CRAE) and central retinal vein equivalent (CRVE) were determined. Age- and 
sex-matched controls from normal subjects were selected from our archived fundus photograph 
library. Visual acuity, visual field area (Goldmann perimetry, V4e white test light), mean 
deviation (Humphrey perimetry, central 10-2 program), and central macular thickness (optical 
coherence tomography) were analyzed for correlations with CRAE and CRVE.
Results: Both CRAE and CRVE were significantly decreased in RP eyes (94.9±13.5 µm and 
155.6±20.0 µm, respectively) compared with control eyes (138.1±14.7 µm and 215.0±20.4 µm, 
respectively, both P0.001). After 3 years of follow-up, visual field area was associated with 
both CRAE (r=0.584, P0.01) and CRVE (r=0.500, P=0.008). A significant association was 
also observed between mean deviation and CRAE (r=0.298, P=0.047). In eyes with RP, a nar-
rower vessel caliber at baseline was associated with a larger decline in visual acuity over the 
3-year follow-up interval (CRAE: r=-0.344, P=0.021; CRVE: r=-0.314, P=0.035).
Conclusion: Retinal vessel caliber is associated with some visual functions in patients with RP.
Keywords: retinitis pigmentosa, retinal vascular caliber, central retinal artery equivalent, 
central retinal vein equivalent
Introduction
Retinitis pigmentosa (RP) is a term used for a group of disorders characterized by an 
inherited progressive degeneration of photoreceptor cells.1 The three hallmark fundus 
characteristics of RP are scattered pigment in the form of bone spicules, attenuated 
blood vessels, and waxy pale discs.2 Among these, only vessel attenuation can be seen 
in the early stages of the disease.3
Alteration of retinal and choroidal vessels and their circulation has been investi-
gated in patients with RP. Many experimental and clinical studies, using laser Doppler 
flowmetry,4–8 magnetic resonance imaging,9,10 and/or ocular pulse amplitude,11 showed 
choroidal and retinal blood flow reductions in patients with RP and/or in animal models 
of RP. Some of these studies quantified the attenuations in retinal vessels.5,6 Another 
study focused on retinal vessel tortuosity and reported that retinal vessels had a higher 
tortuosity in eyes with RP than in normal eyes.12 Therefore, we know that alterations 
in vessels and in ocular circulations occur in eyes with RP. Unfortunately, these 
changes are clinically difficult to follow because measurement of blood flow veloc-
ity and vessel tortuosity require specific devices and/or analyses that are not easily 
performed in the clinical setting.





Over the past decade, quantification of retinal vascular cali-
ber, using fundus photographs, has been widely used in epide-
miological studies.13–18 The Interactive Vessel Analysis (IVAN; 
University of Wisconsin–Madison, Madison, WI, USA) 
program is a well-established method to semi-automatically 
quantify vessel caliber.19,20 Using this program, retinal vessel 
analyses have been performed for patients with various ocular 
diseases, including diabetic retinopathy,21 branch retinal vein 
occlusion,22 age-related macular degeneration,23 and normal-
tension glaucoma.24 Evidence from these reports suggests that 
disease pathogenesis may be linked to vascular alterations.
Recently, Ma et al25 investigated the correlation between 
vessel attenuation and visual function in patients with RP. 
However, as the authors noted, the study was cross-sectional 
and did not provide information on how retinal vascular 
caliber changes over time. Additionally, the study had 
other limitations, including the use of old fundus camera 
models with optics that may have affected vessel caliber 
measurement,26 the exclusion of data from 65% of subjects, 
a lack of control data, and the inclusion of data from both 
eyes of each patient.
In this study, we quantified changes in retinal vessel 
caliber over time in eyes with RP. The study was conducted 
over a 3-year interval to determine whether visual function 
changes were correlated with retinal vessel attenuation.
Materials and methods
study population
In this study, we enrolled 212 patients with RP who visited 
the Department of Ophthalmology at Kyoto University 
Hospital between July 2007 and June 2009. As of July 2012, 
126 of these patients had been followed-up for 3 or more 
years. Of these 126 patients, we included baseline and 3-year 
interval data of those patients who underwent comprehensive 
ophthalmic examinations, including best-corrected visual 
acuity (VA) measurement, fundus photography, static visual 
field test (Humphrey field analyzer, standard 10-2 program), 
kinetic visual field test (Goldmann perimeter), and spectral 
domain optical coherence tomography (SD-OCT). Conven-
tional electroretinography (ERG), recorded according to the 
2008 recommendations of the International Society for Clini-
cal Electrophysiology of Vision,27 was performed at least 
once for each patient. For dark-adapted ERGs (dim white 
stimulus flash of 0.01 cd·s/m2, minimum interval of 2 seconds 
between flashes), those with undetectable responses were cat-
egorized as “non-recordable”. Electroretinogram para meters 
that fell below the normative 95% confidence intervals were 
categorized as “subnormal”.
RP was diagnosed based on the presence of the follow-
ing: night blindness, fundus characteristics consistent with 
RP, ring-shaped or concentric scotomas corresponding to the 
fundus abnormalities, and non-recordable/subnormal ERGs. 
Thirty-five of 126 patients (27.8%) failed to undergo periodic 
examinations, and fundus photographs of adequate quality 
could not be obtained in six patients (4.7%). Thus, the final 
sample consisted of 85 RP patients (67.5%). Data from the 
left eye of each subject were used in analyses, unless there 
was significant media opacity. In these cases, data from the 
right eye were used when possible. To compare central retinal 
artery equivalent (CRAE) and central retinal vein equivalent 
(CRVE) results from RP patients, age- and sex-matched 
normal subjects were selected by using archived fundus 
photographs from our department’s library. Since all the 
participants were Japanese, control subjects were selected 
from a Japanese population.
retinal vessel caliber measurement
A disc-centered photograph was obtained with a digital 
camera (TRC NW6SF; Topcon Corp., Tokyo, Japan) at 
baseline and each follow-up visit. Retinal vascular caliber 
was measured by three trained graders using a computer-
based program, IVAN, and following established, standard-
ized protocols.19,20 All graders were masked to ocular status 
(RP or control) and ocular examination results of the sub-
jects. All arterioles and venules within one-half to one disc 
diameter of the optic disc margin were measured (Figure 1). 
The diameters of the six largest arteries and veins were then 
used to calculate CRAE and CRVE, respectively. Before the 
measurements, 100 standard images were randomly selected 
and analyzed to assess the intra- and inter-grader reliability 
and the intraclass and interclass reproducibility. The intrac-
lass and interclass correlation coefficients (ICC [1.1]) were 
0.907 for CRAE and 0.996 for CRVE. The inter-grader reli-
ability (ICC [3.1]) was 0.854 for CRAE and 0.987 for CRVE. 
Since the measurement of the six largest vessels was not pos-
sible in some cases, we also evaluated the clinical significance 
of the mean of the two largest arterioles/venules.
Optical coherence tomography  
(OCT) acquisition and analysis
At baseline and all follow-up visits, patients underwent 
a dilated OCT examination with SD-OCT (Spectralis® 
HRA + OCT; Heidelberg Engineering, Heidelberg, Ger-
many), performed by an experienced technician. All images 
were obtained using the built-in eye-tracking system, 
and 100 scans were automatically averaged to reduce the 
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 signal-to-noise ratio. The central macular thickness (CMT) 
was defined as the vertical distance between the vitreoretinal 
interface and the outer border of the retinal pigment epithe-
lium, using the horizontal and vertical line scans through the 
foveal center. All measurements were performed manually 
using the SD-OCT built-in calibers. Macular thickness was 
determined by averaging macular thickness measurements 
from the vertical and horizontal OCT scans.
Humphrey field analyzer 10-2 program 
acquisition and analysis
A static visual field test (Swedish Interactive Threshold 
Algorithm standard 10-2 program) was performed with the 
Humphrey field analyzer (Carl Zeiss Meditec AG, Jena, 
Germany). Mean deviation (MD), which is a weighted aver-
age of visual threshold at each measurement position, was 
used for the analysis. When the fixation loss exceeded 20% 
or the false-positive or false-negative error rates were over 
25%, data were excluded from the study.
Visual field examination
Visual field examination (V4e, white test light, Goldmann 
perimeter; Haag Streit, Bern, Switzerland) results were digi-
tally scanned and then analyzed using Image J software (US 
National Institutes of Health, Bethesda, MD, USA; down-
loaded from http://imagejnihgov/ij/). First, the magnification 
scale was calibrated using the radius of the central 30° circle 
on the Goldmann perimeter report. With this  calibration, 
it was determined that 140,500 pixels was equivalent to 
a scanned area of 40.69 cm2 on the visual field recording 
paper. The remaining visual field area, defined by the V4e 
isopter, was measured using the “Measurement” function of 
the Image J software.
ethics approval
This study was performed in accordance with the tenets 
of the Declaration of Helsinki, and was approved by the 
Institutional Review Board/Ethics Committee of the 
Kyoto Graduate School of Medicine (Kyoto, Japan). 
Because only medical records were reviewed, this ret-
rospective study received exempt status and it was not 
mandatory to obtain informed consent from RP or healthy 
control subjects.
Data and statistical analyses
It is well-known that RP has bilateral symmetry,28 there-
fore, measurements in one eye should be representative of 
the fellow eye. Here, data from the left eye of each patient 
were used in analyses whenever possible. If media opaci-
ties in the left eye prevented adequate imaging from being 
obtained, data from the right eye were used. Data are pre-
sented as either mean ± standard deviation or as absolute 
numbers (percentages).
For statistical analyses, VA was measured using the 
Landolt C test and converted to the logarithm of the minimum 
angle of resolution (logMAR) equivalent. The unpaired t-test 
A B
Figure 1 Identification and measurement of the retinal arteriole and venule caliber using the IVAN semi-automated computer imaging program.
Notes: The blue and red shading indicates the selected venule and arteriole area, respectively, used to determine vessel caliber. (A) Color photograph of the left eye of 
a 32-year-old woman in the control group. More than six venules and arterioles could easily be measured in all normal patients. (B) Color photograph of the left eye of a 
22-year-old woman with retinitis pigmentosa. Seven venules and only five arterioles could be measured.
Abbreviation: iVan, interactive vessel analysis.





was used to compare continuous variables, and the chi-square 
test was used to compare categorical variables between 
groups, as appropriate. Correlations among parameters were 
tested for statistical significance using Pearson’s correlation 
test. To adjust for confounding factors, a stepwise linear 
regression model was used, with either CRAE or CRVE as 
the dependent variable and with age, VA, visual field area, 
MD, and CMT as the independent variables. Analyses were 
performed using SPSS software (version 19.0; IBM Japan, 
Tokyo, Japan). Statistical significance was defined as a 
P-value less than 0.05.
Results
Descriptive data
Of the 85 RP eyes included, the six largest arterioles and 
venules were gradable in only 45 eyes (52.9%). In the remain-
ing 40 RP patients (47.1%), we could not calibrate the six 
arterioles, but calibration of the six venules was possible in 
all cases (Figure 1).
Correlations of the baseline parameters
Table 1 summarizes the baseline characteristics of the RP and 
control groups. Two-thirds of RP patients were female, and 
their mean age at baseline was 45.0±16.1 years. Mean CRAE 
was significantly smaller in RP patients (94.9±13.5 µm) 
than in the control group (138.1±14.7 µm, P0.0001), 
as was CRVE (155.6±20.0 µm versus 215.0±20.4 µm, 
P0.0001). There were no significant differences in subject 
history, including diabetes, hypertension, hyperlipidemia, 
heart disease, cardiovascular disease, or smoking habits. 
The clinical baseline characteristics of the patients with RP 
are shown in Table 2. The mean age at disease onset was 
27.4±16.9 years, and the mean disease duration, defined as 
the time from onset of symptoms to the day of examination, 
was 17.6±14.3 years.
Correlations of the follow-up parameters
Disease progression was noted on each examination every 
3 years, as was a decline in visual function (Table 3). 
VA, MD, visual field area, and retinal vessel caliber also 
showed statistically significant worsening at each 3-year 
interval. The relationships between various ocular char-
acteristics and CRAE/CRVE are shown in Table 4. At 
the 3-year follow-up, visual field area was significantly 
associated with both CRAE (r=0.584, P=0.001) and CRVE 
(r=0.500, P=0.008), and the MD was significantly associ-
ated with CRAE (r=0.298, P=0.047). Multivariate linear 
regression analysis showed that each 0.12 µm decrease in 
CRAE corresponded to 1 cm2 of visual field constriction 
in RP patients. Other factors were excluded with stepwise 
analysis. We performed the same analyses on baseline 
vessel caliber and clinical characteristics, which showed 
very similar results.
Correlations of vessel baseline  
and functional changes parameters
We next investigated associations between changes in VA, 
CMT, visual field area, MD, and changes in CRAE and 
CRVE. However, there were no significant associations, 
partly because of wide data dispersion. We also investigated 
the association between baseline retinal vessel caliber and 
visual function changes. Baseline vessel caliber (CRAE 
and CRVE) was inversely associated with VA decline 
(Figure 2), indicating that smaller retinal vessels predicted 
larger declines in VA over 3 years. There was no significant 
correlation with the other measurements.
Table 1 Baseline demographics of participants with retinitis pigmentosa and healthy controls
Analyzed parameters RP Age–sex matched control P-value
number 45 45
sex (male/female) 15/30 15/30 1
age (years) 45.0±16.1 45.1±20.7 0.973
Crae (µm) 94.9±13.5 138.1±14.7 0.0001
CrVe (µm) 155.5±20.0 215.0±20.4 0.0001
aVr 0.6±0.1 0.6±0.1 0.012
Diabetes, no. (%) 0 3 (6.7%) na
hypertension, no. (%) 7 (15.6%) 3 (6.7%) 0.314
hyperlipidemia 2 (4.4%) 4 (8.9%) 0.673
heart disease 2 (4.4%) 4 (8.9%) 0.673
Cardiovascular disease 1 (2.2%) 1 (2.2%) 1
Past or current cigarette smoking, no. (%) 12 (26.7%) 9 (20.0%) 0.618
Notes: Data are means ± standard deviations; unpaired t-test for continuous variables or chi-square test for categorical variables, as appropriate.
Abbreviations: aVr, arteriovenous ratio; Crae, central retinal artery equivalent-6; CrVe, central retinal vein equivalent-6; na, not applicable; no., number; rP, retinitis 
pigmentosa.
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Finally, to include the patients in whom six arterioles 
could not be calibrated, CRAE and CRVE were recalculated, 
in all 85 RP patients, as the average diameter of the two 
largest arterioles and veins, respectively. The associations 
between the mean of largest two arterioles/veins and each 
parameter are summarized in Table 5. Interestingly, these 
values were also associated with visual field area and, in 
addition, VA and MD. These results suggest that even the 
caliber of the largest two vessels, which were always arcade 
vessels, can predict visual changes in RP patients.
Discussion
In this study, we confirmed that retinal vessels significantly 
narrow over a 3-year interval in eyes with RP. We also show 
that retinal vascular caliber attenuation is correlated with 
some visual functions. In addition, our results suggest that 
baseline vessel caliber may be predictive of VA decline in 
the following 3 years. 
Consistent with a previous report,25 both CRAE and 
CRVE were significantly correlated with visual field area. 
While another study showed the association between macular 
thickness and retinal vessel caliber in healthy individuals,29 
this association was not confirmed in our cohort. These results 
provide further information on retinal circulation and retinal 
morphology or function in eyes with RP.
 The mechanisms underlying vascular attenuation in 
the diseased retina remain unclear. One hypothesis is that 
after photoreceptor death, the oxygen requirement of the 
outer retina decreases and excessive oxygen reaches the 
inner retina causing a hyperoxic state, which in turn results 
in vasoconstriction.30–32 Another hypothesis suggests that 
primary photoreceptor death sequentially causes thinning 
of the outer retina. This could result in thickening of the 
extracellular matrix between the migrated retinal pigment 
epithelium cells and the retinal vessels and narrowing of 
the retinal vasculature.1,8 Alternatively, Stone et al33 sug-
gested that after photoreceptor death, synaptic input is lost 
and the decline in trophic factors causes a decreased inner 
retinal metabolism. This may induce vascular remodeling 
and subsequent decreases in blood supply to the residual 
retinal tissue.33 In this study, whereas retinal function was 
associated with vessel caliber at given time points, neither 
changes in retinal function nor macular thickness were 
associated with vascular alteration in the 3-year period. 
Therefore, it is likely that these processes do not occur in 
parallel. Although the result does not provide conclusive 
evidence, the first of the above hypotheses is less likely to be 
the primary one. Considering that oxygen levels are expected 
to change promptly after photoreceptor death, the subsequent 
change in vessel caliber should be more closely associated 
with retinal changes.
VA tended to decline more in patients with narrower base-
line vessels. Although we believe that retinal vessel attenua-
tion fundamentally results from photoreceptor degeneration, 
there may be a mechanism that attenuates vessels. This may 
induce further photoreceptor cell death by loss of trophic 
factors, as already suggested by Stone et al.33 Interestingly, 
modulation of retinal vessels seems to protect photoreceptors 
in a mouse model of RP.34 Alternatively, attenuated vessels 
Table 2 Clinical baseline characteristics of study subjects (n=45)
Characteristics n (%)
Mode of inheritance Autosomal recessive 12 26.7%
Autosomal dominant 6 13.3%
Sporadic 27 60.0%
erg Subnormal 2 4.4%
Non-recordable 43 95.6%
Mean SD
estimated age of onset (Years old) 27.4 16.9
estimated duration (Years) 17.6 14.3
Abbreviations: erg, electroretinogram; sD, standard deviation.
Table 3 Mean change in visual function over 3-year intervals in 
study population with rP
Variable Baseline Follow-up P-value
Crae 94.9±2.0 90.7±1.9 0.001
CrVe 155.6±3.0 152.3±2.8 0.014
aVr 0.6±0.009 0.6±0.010 0.086
Visual acuity (logMar) 0.10±0.04 0.17±0.05 0.008
Mean deviation -15.6±1.3 -16.7±1.4 0.0001
CMT  226.0±11.5 209.4±12.2 0.013
Visual field area (V4e) 103.0±14.9 77.9±13.6 0.0001
Notes: Data are means ± standard deviations; paired t-test for continuous variables, 
as appropriate.
Abbreviations: aVr, arteriovenous ratio; CMT, central macular thickness; Crae, 
central retinal artery equivalent; CrVe, central retinal vein equivalent; logMar, 
logarithm of the minimum angle of resolution; RP, retinitis pigmentosa; visual field 
area (V4e), Goldmann visual field test area for V4e.
Table 4 relationship of various characteristics to central retinal 
arteriolar equivalent and central retinal venular equivalent in 
subjects with retinitis pigmentosa
Characteristic Central retinal  
arteriolar equivalent
Central retinal  
venular equivalent
P-value r P-value r
Visual acuity (logMar) 0.092 -0.254 0.083 -0.262
Mean deviation 0.047 0.298 0.092 0.254
Visual field area (V4e) 0.001 0.584 0.008 0.500
CMT 0.536 0.095 0.314 0.154
Abbreviations: CMT, central macular thickness; logMar, logarithm of the minimum 
angle of resolution; r, Pearson’s correlation coefficient; visual field area (V4e), Goldmann 
visual field test area for V4e.





indicate a more hyperoxic state and higher levels of oxidative 
stress, which is known to be toxic to photoreceptors.35 Further 
investigations are needed to clarify these issues.
Measurement of six arterioles is sometimes difficult 
in eyes with RP, especially in advanced cases. These eyes 
would likely be excluded from clinical trials, but are often 
seen in clinical practice. Therefore, we investigated whether 
or not manually calculating CRAE and CRVE with just two 
arteriole or venule vessel measurements is useful in these 
patients. The mean diameters of the two largest arteries and 
venules were well correlated with visual function and retinal 
morphology. These results suggest these manual CRAE and 
CRVE values may be a useful alternative in clinical practice, 
even in more advanced disease states.
To the best of our knowledge, this is the first report of 
correlations between changes in visual function over time 
and retinal vessel caliber. However, this study has several 
limitations. First, systemic blood pressure and blood glucose 
were not measured at the time of retinal photography and 
imaging. These systemic parameters can alter retinal vascular 
caliber,36 which could have affected the results. Second, this 
study was performed using retrospective data, and we can-
not determine whether retinal vessel attenuation precedes 
or follows retinal degeneration. In summary, quantitative 
assessment of retinal vessel caliber may be useful in assess-
ing the RP stage and predicting VA changes.
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